Enanta Pharmaceuticals
ENTA
#7678
Rank
A$0.55 B
Marketcap
A$19.23
Share price
-1.53%
Change (1 day)
135.35%
Change (1 year)

Enanta Pharmaceuticals (ENTA) - Net assets

Net assets on the balance sheet as of September 2025 : A$96.41 Million

According to Enanta Pharmaceuticals 's latest financial reports the company has A$96.41 Million in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Enanta Pharmaceuticals - Net assets on balance sheet (from 2011 to 2025)

Net assets by year

Year Net assets Change
2024-09-30$A$0.18 B-44.76%
2023-09-30$A$0.33 B-32.51%
2022-09-30$A$0.49 B-9.56%
2021-09-30$A$0.55 B-13.11%
2020-09-30$A$0.63 B-7.18%
2019-09-30$A$0.68 B25.67%
2018-09-30$A$0.54 B41.73%
2017-09-30$A$0.38 B8.8%
2016-09-30$A$0.35 B4.91%
2015-09-30$A$0.33 B98.01%
2014-09-30$A$0.17 B43.55%
2013-09-30$A$0.11 B179.39%
2012-09-30$A$42.42 M88.24%
2011-09-30$A$22.53 M

Net assets for similar companies or competitors

Company Net assets differencediff. Country
AbbVie
ABBV
-A$3.88 Billion-4,115.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
A$118.10 B 122,397.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
A$25.80 B 26,660.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
A$77.33 B 80,106.13%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$27.71 B 28,640.52%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
A$66.67 B 69,050.30%๐Ÿ‡จ๐Ÿ‡ญ Switzerland